Lung Therapeutics: Lung Therapeutics Receives SBIR Award for Kidney Fibrosis Research; Principal Investigator BreAnne Mackenzie Will Speak at 4th Annual IPF Summit 2020/Digital

(marketscreener.com) Lung Therapeutics, Inc., a clinical stage biopharmaceutical company developing novel therapeutics for orphan, pulmonary indications, has been awarded a Small Business Innovation Research Grant of $300,228 from the National Institutes of Health to study potential therapies that target fibrotic processes in the kidneys. Addressing an Unmet...https://www.marketscreener.com/news/Lung-Therapeutics-Receives-SBIR-Award-for-Kidney-Fibrosis-Research-Principal-Investigator-BreAnne-M--31154776/?utm_medium=RSS&utm_content=20200821